Search results for CD103 Antibody

APC Anti-CD103 antibody [Ber-ACT8], Abcam, AB176500

FITC Anti-CD103 antibody [Ber-ACT8], Abcam, AB239247

Anti-CD103 antibody [EPR4166] - BSA and Azide free, Abcam, AB247672

ab247672 is the carrier-free version of ab108503 . Clone EPR4166 is different from clone EPR4166(2). Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Conjugation ready Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications. Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold. Compatibility This product is compatible with the Maxpar ® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar ® is a trademark of Fluidigm Canada Inc.

Anti-CD103 antibody [SP301] - BSA and Azide free, Abcam, AB245746

ab245746 is the carrier-free version of ab227697 . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Conjugation ready Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications. Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold. Compatibility This product is compatible with the Maxpar ® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar ® is a trademark of Fluidigm Canada Inc.

FITC anti-mouse CD103 Antibody, CD103, W19396D, BioLegend, 110907

Clone W19396D can partially block binding of clone 2E7 on target cells.

FITC anti-mouse CD103 Antibody, CD103, W19396D, BioLegend, 110908

Clone W19396D can partially block binding of clone 2E7 on target cells.

APC anti-mouse CD103 Antibody, CD103, W19396D, BioLegend, 110905

Clone W19396D can partially block binding of clone 2E7 on target cells.

APC anti-mouse CD103 Antibody, CD103, W19396D, BioLegend, 110906

Clone W19396D can partially block binding of clone 2E7 on target cells.

PE anti-mouse CD103 Antibody, CD103, W19396D, BioLegend, 110903

Clone W19396D can partially block binding of clone 2E7 on target cells.

PE anti-mouse CD103 Antibody, CD103, W19396D, BioLegend, 110904

Clone W19396D can partially block binding of clone 2E7 on target cells.